Literature DB >> 990632

The behavioural effects of EOS-induced changes in substantia nigra GABA levels [proceedings].

G Koob, M del Fiacco, S D Iversen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 990632      PMCID： PMC1667580     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  2 in total

1.  Proceedings: Comparison of circling behaviour following unilateral inhibition of GABA-transaminase or discrete electroyltic lesioning in the rat substantia nigra.

Authors:  A Dray; L J Fowler; N R Oakley; M A Simmonds; T Tanner
Journal:  Br J Pharmacol       Date:  1975-10       Impact factor: 8.739

2.  Rotational behaviour following inhibition of GABA metabolism unilaterally in the rat substantia nigra.

Authors:  N R Oakley; M A Simmonds
Journal:  J Pharm Pharmacol       Date:  1975-08       Impact factor: 3.765
  2 in total
  4 in total

1.  GABA-like properties of flurazepam and baclofen suggested by rotational behaviour following unilateral intranigral injection: a comparison with the GABA agonist muscimol [proceedings].

Authors:  J L Waddington
Journal:  Br J Pharmacol       Date:  1977-06       Impact factor: 8.739

2.  Rotational behaviour and cGMP responses following manipulation of nigral mechanisms with chlordiazepoxide. Evidence for enhancement of GABA transmission by benzodiazepines.

Authors:  J L Waddington; A Longden
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-11       Impact factor: 3.000

3.  Cataleptic and anticataleptic effects of muscimol and gabaculine injected into globus pallidus and substantia nigra, and interactions with haloperidol or benzodiazepines.

Authors:  Y Matsui; T Kamioka
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-12       Impact factor: 3.000

4.  Induction of rotational behaviour by intranigral baclofen suggests possible GABA-agonist activity.

Authors:  J L Waddington
Journal:  Experientia       Date:  1977-10-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.